Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 218 of 218 entries
View as:

Dermatopharmacokinetic Trial of LEO 90100 Foam

Phase: N/A Priority: Normal
NCT ID: NCT03476746 Org: User:
Start: 03/20/18 End: 07/01/18 Due: 07/01/19

LEO 124249 Ointment in the Treatment of Alopecia Areata

Phase: N/A Priority: Normal
NCT ID: NCT02561585 Org: User:
Start: 01/31/16 End: 12/31/16 Due: 12/31/17

Biological Effects of LEO 43204 in Actinic Keratosis

Phase: N/A Priority: Normal
NCT ID: NCT02600598 Org: User:
Start: 07/31/16 End: 01/16/17 Due: 01/16/18

LEO 90105 Ointment in Japanese Subjects With Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01422434 Org: User:
Start: 07/31/11 End: 04/30/12 Due: 04/30/13

Efficacy and Safety of 3 Doses of HL10 Given at Fixed Time Intervals Compared to Standard Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00742482 Org: User:
Start: 01/31/03 End: 06/30/05 Due: 06/30/06

Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis.

Phase: N/A Priority: Normal
NCT ID: NCT01447758 Org: User:
Start: 09/30/11 End: 03/31/13 Due: 03/31/14

LEO 27847 - A Study in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01007383 Org: User:
Start: 09/30/09 End: 04/30/10 Due: 04/30/11

Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00051545 Org: User:
Start: 11/30/99 End: 06/30/04 Due: 06/30/05

A Proof of Concept Study Comparing Three Doses of an Oral Solution of LEO 22811 With a Placebo Oral Solution for the Treatment of Psoriasis Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT01116895 Org: User:
Start: 05/31/10 End: 07/31/11 Due: 07/31/12

Safety, Tolerability and Pharmacokinetics in AD Subjects and Healthy Subjects of Cutaneous Application of LEO 39652 Cream

Phase: N/A Priority: Normal
NCT ID: NCT01850849 Org: User:
Start: 05/31/13 End: 12/31/14 Due: 12/31/15

Xamiol®Gel in BODY Psoriasis: A One-year Non-interventional Study

Phase: N/A Priority: Normal
NCT ID: NCT02636101 Org: User:
Start: 01/31/16 End: 02/15/18 Due: 02/15/19

LEO 32731 - A Phase I Study in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02514694 Org: User:
Start: 07/31/15 End: 12/31/15 Due: 12/31/16

LEO 90100 Aerosol Foam Compared to Calcipotriol Plus Betamethasone Dipropionate Gel in Subjects With Psoriasis Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT02132936 Org: User:
Start: 06/30/14 End: 02/28/15 Due: 02/28/16

Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Scalp Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00216840 Org: User:
Start: 12/31/04 End: 09/30/05 Due: 09/30/06

Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Face or Chest Including 12-month Follow-up

Phase: N/A Priority: Normal
NCT ID: NCT02547233 Org: User:
Start: 11/30/15 End: 11/30/17 Due: 11/30/18

Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND

Phase: N/A Priority: Normal
NCT ID: NCT03587805 Org: User:
Start: 03/18/18 End: 07/03/24 Due: 07/03/25

A Multi-Centre Clinical Trial to Evaluate a Left-Right Design in Adults With Mild to Moderate Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT02103725 Org: User:
Start: 04/30/14 End: 09/30/14 Due: 09/30/15

Efficacy, Safety, and Tolerability of TD1414 2% Cream in Impetigo and Secondarily Infected Traumatic Lesions (SITL)

Phase: N/A Priority: Normal
NCT ID: NCT00626795 Org: User:
Start: 02/29/08 End: 06/30/09 Due: 06/30/10